Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Leases: 2015-2024

Historic Current Leases for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $7.6 million.

  • Wave Life Sciences' Current Leases rose 13.46% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 13.46%. This contributed to the annual value of $7.6 million for FY2024, which is 13.76% up from last year.
  • As of FY2024, Wave Life Sciences' Current Leases stood at $7.6 million, which was up 13.76% from $6.7 million recorded in FY2023.
  • Wave Life Sciences' 5-year Current Leases high stood at $7.6 million for FY2024, and its period low was $3.7 million during FY2020.
  • In the last 3 years, Wave Life Sciences' Current Leases had a median value of $6.7 million in 2023 and averaged $6.6 million.
  • Data for Wave Life Sciences' Current Leases shows a peak YoY skyrocketed of 33.58% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Wave Life Sciences' Current Leases stood at $3.7 million in 2020, then soared by 33.58% to $5.0 million in 2021, then increased by 10.78% to $5.5 million in 2022, then climbed by 22.16% to $6.7 million in 2023, then rose by 13.76% to $7.6 million in 2024.